Peritoneal Neoplasms - 29 Studies Found Recruiting : An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA) : Peritoneal Neoplasms : 2012-09-28 Completed : Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers : Peritoneal Neoplasms : 2008-04-23 : Drug: nanoparticulate paclitaxel This is a Phase 1, dose-escalation study with 6 cohorts of 1 - 6 patien Active, not recruiting : Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With Cisplatin : Peritoneal Neoplasms : 2007-07-16 : Behavioral: Questionnaire QOL Questionnaires taking a total of 10 minutes to complete. Terminated : A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis : Peritoneal Neoplasms : 2006-07-14 : Procedure: Surgical debulking with peritonectomy Active, not recruiting : BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer : Ovarian Cancer, Peritoneal Neoplasms : 2013-02-08 Withdrawn : Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC : Peritoneal Neoplasms Echocardiography Guided Fluid Management : 2010-07-14 : Device: Echocardiogram Echocardiography will be utilized during the procedure to guide fluid management. Completed : Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec) : Primary Peritoneal Neoplasm Secondary Per : 2013-06-10 : Drug: Goal Directed Intravenous Restrictive Fluid Therapy Not yet recruiting : An Observational Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer : Ovarian Cancer, Peritoneal Neoplasms : 2013-08-27 Terminated : A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer : Ovarian Cancer Peritoneal Neoplasms : 2007-08-14 : Drug: Volociximab 15 mg/kg weekly, IV infusions, for 8 weeks or until disease progression or unacceptabl Completed : Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis : Carcinoma Peritoneal Neoplasm : 1999-11-03 : Drug: Cisplatin Drug: Paclitaxel Next >>>